Verschoor N, Bos MK, de Kruijff IE, Van MN, et al. Trastuzumab and first-line taxane chemotherapy in metastatic breast cancer patients with a HER2-negative tumor and HER2-positive circulating tumor cells: a phase II trial. Breast Cancer Res Treat 2024 Jan 31. doi: 10.1007/s10549-023-07231.
PMID: 38291268